A related editorial notes that the vaccine is not yet approved and that more data on efficacy are needed before it can be widely deployed. A Global Ebola Vaccine Implementation Team has however been preparing the ground for the vaccine’s introduction, if the evidence is sufficient for its licensing - creating guidelines for its use, strategies for community engagement, and mechanisms to expand country capacity for distribution and delivery. In addition, the GAVI Alliance has approved substantial funding for the vaccine’s procurement and deployment.